sa.vogel
TL2 · Nijmegen
Contributes reviews on supplier material. Based in Nijmegen.
Joined 25 November 2024 · last posted 1d
92 posts, newest first. Showing up to 150.
-
Request: a per-category review queue Replied, post #134 · Meta › Feature requests · 27 Jul 2026 · 1 like Deprecation requests: if you think a feature should be removed or changed, that is also a request. Explain why you think it would improve the site.
-
Priming a pen and whether the primed volume is wasted Replied, post #17 · Devices › Pens & autoinjectors · 22 Jul 2026 · 0 likes Picking up post #14: that is the part I would want checked first. The instruction leaflet for a licensed pen is a genuinely good technical document and is almost never…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #88 · Wellbeing › Sleep · 18 Jul 2026 · 10 likes On post #84 — agreed on the reasoning, with one qualification. The reason Sleep apnoea is hard to answer is that the obvious measurement and the relevant quantity are…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #44 · Compounds › Secretagogues & GH axis · 14 Jul 2026 · 32 likes Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for what they claim: less effect on cortisol and prolactin…
-
Evidence quality in the secretagogue literature: an honest assessment Replied, post #2 · marked as the solution · Compounds › Secretagogues & GH axis · 12 Jul 2026 · 10 likes The opening post is right about the mechanism and I think understates the practical bit. The pulsatile character of endogenous growth hormone release is why a…
-
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #21 · Clinical › Comorbidities · 12 Jul 2026 · 7 likes I read post #20 twice before replying, because I had assumed the opposite. Where two conditions pull in opposite directions, that is a clinical judgement rather than a…
-
Immortal time bias in a claims-database study — one year on Replied, post #15 · Evidence › Study critique · 9 Jul 2026 · 0 likes Blinding, duration and comparator choice trade against each other. Improving one usually costs another, and a critique that ignores the trade is incomplete. Posting it…
-
Submitting a sample: the process end to end Replied, post #69 · Sourcing › Independent verification · 9 Jul 2026 · 0 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. The short…
-
Type 1 diabetes: off-label use and the evidence gap Started this topic · Clinical › Special populations · 5 Jul 2026 · 41 likes On the subject in the title: Type 1 diabetes: off-label use and the evidence gap Working notes rather than a conclusion. Type 1 diabetes, and specifically the version…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #35 · Practice › Dosing & titration · 3 Jul 2026 · 11 likes Half steps are arithmetically simple and pharmacologically unstudied. They are not dangerous in any obvious way and they are also not what the evidence describes, and…
-
Athletes in weight-category sports: a different risk calculus Replied, post #8 · marked as the solution · Clinical › Special populations · 30 Jun 2026 · 10 likes Post #7 answers the question as asked. The question underneath it is different. Athletes in weight-category sports is a question about a distribution, not about a…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #84 · Start Here › How to Ask · 30 Jun 2026 · 0 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #65 · Start Here › How to Ask · 23 Jun 2026 · 16 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #22 · Analytics › Home & field testing · 23 Jun 2026 · 0 likes Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are…
-
Tracking intake honestly when appetite is absent Replied, post #69 · Nutrition & Training › Protein & intake · 22 Jun 2026 · 2 likes Nothing here is medical or dietetic advice, and a dietitian is the professional this subcategory most often recommends.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #24 · Pharmacology › Receptor biology · 22 Jun 2026 · 2 likes Agreed on all of that, and I have nothing to add to it.
-
Racemisation and why it is invisible to a mass measurement — what changed since Replied, post #12 · Analytics › Impurities & related substances · 20 Jun 2026 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #40 · Compounds › Repair & healing peptides · 11 Jun 2026 · 30 likes Following this. I have the same question and no better information than the first post.
-
The headache that turns out to be dehydration — the long version Replied, post #48 · Nutrition & Training › Hydration & electrolytes · 9 Jun 2026 · 10 likes Worth separating two things that post #44 runs together. Commercial rehydration formulations are designed for a specific purpose and are not equivalent to a sports…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #31 · Compounds › Retatrutide · 8 Jun 2026 · 22 likes Good question, well framed, and I would like to see it answered properly.
-
Follow-up: Sleep quality changes during weight loss Replied, post #35 · Wellbeing › Sleep · 1 Jun 2026 · 5 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher.
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #80 · Practice › Side effects · 13 May 2026 · 12 likes Nobody has said the unglamorous part of Dizziness on standing yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #51 · Practice › Reconstitution · 13 May 2026 · 0 likes I read post #50 twice before replying, because I had assumed the opposite. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither…
-
Delayed gastric emptying and oral medication absorption: which drugs matter — one year on Replied, post #3 · marked as the solution · Practice › Interactions · 10 May 2026 · 8 likes Post #2 is right about the mechanism and I think understates the practical bit. Mechanistic reasoning about interactions has a poor predictive record. It is a good way…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #35 · Practice › Administration · 3 May 2026 · 27 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Batch numbers that do not match the vial label — what changed since Replied, post #4 · Sourcing › Red flags · 28 Apr 2026 · 3 likes On the opening post — agreed on the reasoning, with one qualification. Keep the two claims separate. "The result on this lot did not match the certificate" is a report…
-
Journal club: is percentage weight change the right endpoint? Replied, post #103 · Evidence › Journal club · 25 Apr 2026 · 9 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. Not a…
-
CJC-1295 with and without DAC: what the modification does Replied, post #39 · Compounds › Secretagogues & GH axis · 22 Apr 2026 · 0 likes Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably less so in solution. Reconstituting only what will be used within…
-
Coming back to: Measurement error in a self-reported exposure Replied, post #6 · Evidence › Study critique · 20 Apr 2026 · 1 like Reading rather than contributing, but this is the most useful thread I have found on it.
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #3 · Sourcing › Independent verification · 13 Apr 2026 · 1 like Post #2 is right about the mechanism and I think understates the practical bit. The record shows what was measured. Everything beyond that is inference and this site…
-
Five questions in one post gets you one answer — how to split them Replied, post #51 · Start Here › How to Ask · 9 Apr 2026 · 0 likes On post #47 — agreed on the reasoning, with one qualification. The most useful reply I ever got about five questions was a request to state my units. It sounds like…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #66 · Analytics › Mass spectrometry · 9 Apr 2026 · 13 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #64 · Practice › Administration · 6 Apr 2026 · 7 likes Bookmarking this. I will come back when I have something worth adding.
-
Area percent versus weight percent: the confusion that causes most arguments Replied, post #2 · Analytics › HPLC & UHPLC · 31 Mar 2026 · 5 likes No disagreement from me. Posting only so the question does not look ignored.
-
Preprint servers and what screening they do Replied, post #82 · Evidence › Preprints · 9 Mar 2026 · 10 likes Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry the same weight. This is where my knowledge stops and I would rather…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #14 · Sourcing › Red flags · 8 Mar 2026 · 12 likes Worth separating two things that post #10 runs together. Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #40 · Research Methods › Statistics · 25 Feb 2026 · 0 likes Understood. Thank you for being specific about the limits of it.
-
Amylin receptor signalling and satiety — what changed since Replied, post #27 · Pharmacology › Receptor biology · 8 Feb 2026 · 22 likes Signalling through cyclic AMP is the canonical pathway and is not the only one. Beta-arrestin recruitment differs between ligands and its clinical significance here is…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #16 · Pharmacology › Pharmacokinetics · 15 Jan 2026 · 8 likes Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #78 · Compounds › Tirzepatide · 11 Dec 2025 · 17 likes Counterpoint on Tirzepatide in type 2 diabetes, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the…
-
What pooling buys you and what it destroys Replied, post #83 · Evidence › Meta-analyses · 4 Dec 2025 · 13 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
A parcel stationary at a customs facility for nine days Replied, post #9 · Sourcing › Logistics · 3 Dec 2025 · 10 likes This follows post #6 rather than contradicting it. Photographing the parcel on arrival before opening it takes ten seconds and is the difference between a report and a…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #95 · Practice › Reconstitution · 26 Nov 2025 · 0 likes Picking up post #92: that is the part I would want checked first. Preservative effectiveness is tested against a defined microbial challenge under defined conditions.…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #56 · Practice › Interactions · 24 Nov 2025 · 29 likes Picking up post #53: that is the part I would want checked first. I keep a log for Warfarin and altered intake specifically because my memory of it turned out to be…
-
[2026 update] What steady state means for the decision to escalate Replied, post #41 · Practice › Dosing & titration · 9 Nov 2025 · 0 likes A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are perturbing a slowly moving average, and the labelling for licensed…
-
Follow-up: Why appetite effects are mostly central Replied, post #83 · Pharmacology › Receptor biology · 1 Nov 2025 · 16 likes Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors. Semaglutide has some activity on other receptors; tirzepatide…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #25 · Start Here › How to Ask · 25 Oct 2025 · 23 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. Two sources, same conclusion, and I…
-
EMA product information as a primary source Replied, post #2 · Regional › European Union · 24 Oct 2025 · 5 likes What I can speak to on EMA product information is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #100 · Lounge › Off topic · 16 Oct 2025 · 10 likes No disagreement from me. Posting only so the question does not look ignored.
-
Pricing far outside the range, in either direction Replied, post #4 · Sourcing › Red flags · 26 Sep 2025 · 0 likes Prices well below the rest of the market are a fact rather than a finding. They are worth noting and they do not establish anything on their own.
-
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Replied, post #6 · Compounds › Tirzepatide · 22 Sep 2025 · 5 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Reading a supplier's product description as a marketing document Replied, post #70 · Compounds › Other compounds · 13 Sep 2025 · 13 likes On analysis: unusual or modified sequences are exactly where a default reversed-phase method is least likely to be appropriate. A supplier that runs everything on one…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #53 · Practice › Reconstitution · 8 Sep 2025 · 0 likes Agreed on all of that, and I have nothing to add to it.
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #16 · Devices › Pens & autoinjectors · 26 Aug 2025 · 1 like Post #15 is right about the mechanism and I think understates the practical bit. Reusability: some pens are single-use (throw away after one injection). Others can be…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #30 · Analytics › Mass spectrometry · 22 Aug 2025 · 21 likes Mass error in parts per million is (observed minus theoretical) divided by theoretical, times a million. On a high-resolution instrument a low single-digit figure is…
-
A request that was declined, and the reasoning — a second dataset Replied, post #88 · Documentation › Wiki requests · 14 Aug 2025 · 0 likes Documents that are mostly a worked example age better than documents that are mostly a summary, because the arithmetic does not change. That is the shape of it. The…
-
A request that was declined, and the reasoning — a second dataset Replied, post #63 · Documentation › Wiki requests · 12 Aug 2025 · 10 likes Coming back to post #61, because the follow-up matters more than the original answer. The most useful requests here identify a specific confusion that keeps recurring…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #149 · Devices › Cold chain · 24 Jul 2025 · 9 likes Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is standard refrigerator temperature. Check your refrigerator's actual…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #139 · Compounds › Tirzepatide · 17 Jul 2025 · 28 likes No disagreement from me. Posting only so the question does not look ignored.
-
Regional warehouse stock versus direct despatch Replied, post #6 · Sourcing › Logistics · 14 Jul 2025 · 15 likes Good question, well framed, and I would like to see it answered properly.
-
Sodium, potassium and magnesium when intake drops Replied, post #34 · Nutrition & Training › Hydration & electrolytes · 28 Jun 2025 · 10 likes Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte depletion. Increasing fluids, salt, and potassium usually resolves…
-
Vagal afferents and the gut-brain pathway Replied, post #8 · Pharmacology › Receptor biology · 19 Jun 2025 · 2 likes Thank you — that answers what I came here to find out.
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #31 · Evidence › Trials · 13 Jun 2025 · 4 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #54 · Access › Insurance & coverage · 10 Jun 2025 · 0 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #99 · Clinical › Comorbidities · 30 May 2025 · 17 likes Worth separating two things that post #95 runs together. The honest answer on obstructive sleep apnoea is that it depends, and the useful part is the list of what it…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #8 · Evidence › Journal club · 18 May 2025 · 1 like Post #7 is right about the mechanism and I think understates the practical bit. The summary that goes to the digest should say what the paper establishes, what it does…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #89 · Wellbeing › Mental health · 16 May 2025 · 0 likes Good question, well framed, and I would like to see it answered properly.
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #41 · Compounds › Cagrilintide & amylin analogues · 12 May 2025 · 10 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
-
Counter-ion content and its effect on measured mass Replied, post #33 · Analytics › Mass spectrometry · 7 May 2025 · 1 like What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
-
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #10 · Clinical › Bloodwork · 23 Apr 2025 · 0 likes Where I would push back on the Building a sensible monitoring schedule consensus is the confidence, not the direction. The direction looks right. The confidence is…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #92 · Compounds › Cagrilintide & amylin analogues · 4 Apr 2025 · 27 likes Native amylin has awkward physical properties — it aggregates readily, which is why a stable analogue is a pharmaceutical achievement rather than a formulation detail.
-
What happens after your first post: likes, trust levels, and why none of it matters much Replied, post #7 · marked as the solution · Start Here › Welcome · 23 Mar 2025 · 18 likes Likes here mean "this helped", not "I agree". People like posts that argue against them, and that is deliberate.
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #22 · Compounds › Secretagogues & GH axis · 10 Mar 2025 · 3 likes Coming back to post #20, because the follow-up matters more than the original answer. The reason Tesamorelin keeps being re-asked is that the answer is conditional and…
-
Ipamorelin selectivity claims and where they came from Replied, post #18 · Compounds › Secretagogues & GH axis · 6 Mar 2025 · 2 likes Worth separating two things that post #15 runs together. Taking ipamorelin selectivity claims seriously for a moment rather than deflecting: the honest position is that…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #71 · Compounds › Cagrilintide & amylin analogues · 24 Feb 2025 · 16 likes Post #70 is right about the mechanism and I think understates the practical bit. The interest in combining it with semaglutide is that two different satiety mechanisms…
-
Consistent declarations and why they matter more than clever ones Replied, post #44 · Sourcing › Logistics · 17 Feb 2025 · 15 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #90 · Evidence › Meta-analyses · 10 Feb 2025 · 5 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Reading an MS report that only gives you a single number Replied, post #6 · Analytics › Mass spectrometry · 6 Feb 2025 · 7 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #46 · Devices › Cold chain · 3 Feb 2025 · 1 like Post #45 is right about the mechanism and I think understates the practical bit. Temperature logging: devices that record temperature over time let you confirm cold…
-
Reading a supplementary appendix and finding the interesting part Replied, post #58 · Evidence › Trials · 2 Jan 2025 · 21 likes On post #54 — agreed on the reasoning, with one qualification. Reading the supplementary appendix is where most of the real information is, and it is where almost…
-
Coming back to: When to suspect the method rather than the sample Replied, post #59 · Analytics › Method validation · 11 Dec 2024 · 6 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #42 · Access › Insurance & coverage · 26 Nov 2024 · 0 likes That is clearer than the version I had in my head. Thank you.
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #37 · Compounds › Tirzepatide · 15 Nov 2024 · 31 likes Comparisons between the tirzepatide and semaglutide programmes across trials rather than within one are weak. Different populations, different durations, different…
-
Follow-up: What this community means by "a source", in practical terms Replied, post #12 · Start Here › Welcome · 6 Nov 2024 · 0 likes Helpful, and easy to find again, which is half of what a good reply is.
-
Melanocortin agonists: mechanism and the documented adverse profile Replied, post #10 · Compounds › Other compounds · 2 Nov 2024 · 4 likes This follows post #7 rather than contradicting it. PT-141 was developed from the same family with a different receptor profile, and it has a considerably better…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #85 · Compounds › Other compounds · 31 Oct 2024 · 0 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #66 · Compounds › Other compounds · 22 Oct 2024 · 13 likes Coming back to post #64, because the follow-up matters more than the original answer. I keep a log for Melanocortin agonists specifically because my memory of it turned…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #130 · Clinical › Bloodwork · 21 Oct 2024 · 3 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #14 · Practice › Administration · 7 Sep 2024 · 26 likes I read post #12 twice before replying, because I had assumed the opposite. Two claims get bundled together under site rotation scheme and they need separating. The…
-
Guidelines revision: what changed and why Replied, post #26 · Meta › Announcements · 25 Jul 2024 · 9 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #36 · Compounds › Retatrutide · 18 Jul 2024 · 22 likes On post #33 — agreed on the reasoning, with one qualification. Retatrutide is investigational. Material obtained outside a clinical trial is research-use-only by…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #19 · Practice › Dosing & titration · 12 Jun 2024 · 0 likes On post #16 — agreed on the reasoning, with one qualification. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add…